How cannabinoids affect inflammation and distress in people living with HIV
The impact of cannabinoids on inflammation, HIV viral load and symptoms of distress among persons living with HIV
This study is looking at how cannabinoids, like cannabidiol, might help reduce inflammation and improve well-being in people living with HIV, so we can find better treatment options for you.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Science Center NIH-funded |
| Lab location | 1 site (San Antonio, United States) |
| Project ID | NIH-10646317 on NIH RePORTER |
What this research studies
This research investigates the effects of cannabinoids, such as cannabidiol, on inflammation, HIV viral load, and symptoms of distress in individuals living with HIV. The study aims to understand how these compounds may influence health outcomes by analyzing clinical trial data and behavioral interventions. Patients will be monitored for changes in their health status, including inflammation levels and psychological well-being, as they use cannabinoid products. The research is designed to provide insights that could lead to improved treatment options for those affected by HIV.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who may be experiencing inflammation and psychological distress.
Not a fit: Patients who are not living with HIV or those who do not experience inflammation or distress may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that utilize cannabinoids to improve health outcomes for people living with HIV.
How similar studies have performed: While some studies have explored the effects of cannabinoids on various health conditions, the specific focus on HIV and its related symptoms is relatively novel and under-researched.
Where this research is happening
San Antonio, United States
- University of Texas Hlth Science Center — San Antonio, United States (Active)
Researchers
- Principal investigator: Okafor, Chukwuemeka Nkemakonam — University of Texas Hlth Science Center
- Study coordinator: Okafor, Chukwuemeka Nkemakonam
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.